Y1 (tobacco)

Last updated

Y1 is a strain of tobacco that was cross-bred by Brown & Williamson to obtain an unusually high nicotine content. It became controversial in the 1990s when the United States Food and Drug Administration (FDA) used it as evidence that tobacco companies were intentionally manipulating the nicotine content of cigarettes. [1] Y1 has also been investigated by the Pan American Health Organization (PAHO). [2]

Contents

Development and use

Y1 was developed by tobacco plant researcher James Chaplin, [3] for Brown & Williamson, then a subsidiary of British American Tobacco, in the late 1970s, with the approval of the president at the time, Joseph E. Edens. [4] Chapin, a director of the USDA Research Laboratory at Oxford, North Carolina, [5] had described the need for a higher nicotine tobacco plant in the trade publication World Tobacco in 1977. [3] Chapin had bred a number of high-nicotine strains based on a hybrid of Nicotiana tabacum and Nicotiana rustica , [5] but they were weak and would blow over in a strong wind.

B&W tested five strains on a farm in Wilson, North Carolina in 1983. Only two grew to maturity; Y2, which "turned black in the drying barn and smelled like old socks," and Y1, which was a success. [3] B&W brought the plants to California company DNA Plant Technology for additional modification, including making the plants male-sterile, a procedure that prevents competitors from reproducing the strain from seeds. [3] DNA Plant Technology then smuggled the seeds to a B&W subsidiary in Brazil. [6] A 1991 industry document analyzing the potential of Y1 reported that it had been successfully grown in Brazil, Honduras and Zimbabwe but not Venezuela, and that it was both difficult to cure and susceptible to Granville wilt. [4]

Brown & Williamson initially attempted to patent Y1 in the United States in 1991; this was denied. A year later, B&W attempted to patent Y1 in Brazil; this was also denied. An appeal against the US patent denial was rejected in 1994, and later that year all patent applications were withdrawn. [5]

Y1 has a higher nicotine content than conventional flue-cured tobacco (6.5% versus 3.2—3.5%). [7] It has a comparable amount of tar, and does not affect taste or aroma. [8] British American Tobacco (BAT) began to discuss the trialling of Y1 tobacco in 1991, [9] despite it not being approved for use in the United States. [4] One ex-employee of BAT stated that Y1 tobacco started to be widely used in cigarettes in the US in 1993. Tobacco company executives initially denied intentionally manipulating nicotine levels in cigarettes, but eventually acknowledged blending Y1 into brands including Raleigh, Prime and Summit in order to maintain the flavor and nicotine level of the product while lowering the tar content. [10]

B&W continued to insist that Y1 was not used to raise nicotine levels, stating "the brands that use Y1 deliver essentially the same nicotine as the products they replaced." [11] B&W promised in 1994 to stop using Y1, but at that time they had 7 million pounds of inventory, and continued to blend Y1 into their products until 1999. [10] Y1 was also shipped to BAT's cigarette plant in Southampton, England and to subsidiaries in Germany and Finland, but whether it was used in commercial production is unclear. [3]

Beginning in 1990, the United States Food and Drug Administration (FDA), under Commissioner David Kessler, conducted an investigation into the tobacco industry, including charges that cigarette manufacturers intentionally manipulated nicotine levels in cigarettes to keep their customers addicted. In early 1994, B&W told the FDA that there was an agreement among US cigarette manufacturers not to manipulate nicotine levels in tobacco. [3] However, FDA investigators discovered a Brazilian patent describing a tobacco plant with an unusually high nicotine content, which led them to B&W and Y1. [11]

In testimony before Congress in June 1994, Kessler accused B&W of knowingly manipulating nicotine levels in some of its cigarettes. B&W chairman Thomas Sandefur rejected the claim, stating that "the brands that use Y1 deliver essentially the same nicotine as the products they replaced" and accusing Kessler of "grandstanding" for political purposes. [11] Several members of Congress suggested that this proved that tobacco executives had committed perjury when they denied knowing smoking was addictive in their April 1994 testimony before Congress. [11]

Y1 became an important piece of evidence in FDA v. Brown & Williamson Tobacco Corp. , a lawsuit in which the FDA attempted to exert its authority under the Federal Food, Drug, and Cosmetic Act to regulate tobacco products. Kessler argued that because Y1 had been raised for its higher nicotine level, it was subject to FDA regulation as a pharmacological product, and therefore its importation and sale in the US without the proper FDA approval was illegal. [1] The FDA also targeted DNA Plant Technology, charging that it had illegally smuggled the Y1 seeds out of the United States. [12] [13]

The Justice Department charged DNA Plant Technology with one misdemeanor count of conspiracy to violate the Tobacco Seed Export law, prohibiting the export of tobacco seeds without a permit, a law which was repealed in 1991. [12] [13] DNA Plant Technology pleaded guilty in 1998 and agreed to cooperate with further investigations of B&W. [6] However, the Supreme Court eventually ruled in March 2000 that the FDA did not have the authority to regulate tobacco as a drug. [14]

The discovery of Y1 fueled allegations that B&W intentionally used Y1 tobacco to increase the addictiveness of its products, resulting in a number of lawsuits. [2] [15] The state of Minnesota heavily referred to Y1 tobacco in its 1997 trial against the American tobacco industry (State of Minnesota et al. v. Philip Morris, Inc., et al.), [16] a trial which took place prior to the inception of the Tobacco Master Settlement Agreement in November 1998. [17]

Related Research Articles

<span class="mw-page-title-main">Tobacco</span> Agricultural product processed from the leaves of plants in genus nicotiana

Tobacco is the common name of several plants in the genus Nicotiana of the family Solanaceae, and the general term for any product prepared from the cured leaves of these plants. More than 70 species of tobacco are known, but the chief commercial crop is N. tabacum. The more potent variant N. rustica is also used in some countries.

<span class="mw-page-title-main">Nicotine</span> Mild chemical stimulant produced by some plants

Nicotine is a naturally produced alkaloid in the nightshade family of plants and is widely used recreationally as a stimulant and anxiolytic. As a pharmaceutical drug, it is used for smoking cessation to relieve withdrawal symptoms. Nicotine acts as a receptor agonist at most nicotinic acetylcholine receptors (nAChRs), except at two nicotinic receptor subunits where it acts as a receptor antagonist.

<span class="mw-page-title-main">Brown & Williamson</span> American tobacco company

Brown & Williamson Tobacco Corporation was a U.S. tobacco company and a subsidiary of multinational British American Tobacco that produced several popular cigarette brands. It became infamous as the focus of investigations for chemically enhancing the addictiveness of cigarettes. Its former vice-president of research and development, Jeffrey Wigand, was the whistleblower in an investigation conducted by CBS news program 60 Minutes, an event that was dramatized in the film The Insider (1999). Wigand claimed that B&W had introduced chemicals such as ammonia into cigarettes to increase nicotine delivery and increase addictiveness.

<span class="mw-page-title-main">Nicotine patch</span> Transdermal patch that releases nicotine into the body

A nicotine patch is a transdermal patch that releases nicotine into the body through the skin. It is used in nicotine replacement therapy (NRT), a process for smoking cessation. Endorsed and approved by the U.S. Food and Drug Administration (FDA), it is considered one of the safer NRTs available for the treatment of tobacco use disorder.

FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120 (2000), is an important United States Supreme Court case in U.S. administrative law. It ruled that the Food, Drug, and Cosmetic Act did not give the Food and Drug Administration (FDA) the authority to regulate tobacco products as "drugs" or "devices." This was later superseded by the Family Smoking Prevention and Tobacco Control Act, which granted the FDA the authority to regulate such products.

<span class="mw-page-title-main">David A. Kessler</span> American pediatrician & attorney (born 1951)

David Aaron Kessler is an American pediatrician, attorney, author, and administrator serving as Chief Science Officer of the White House COVID-19 Response Team since 2021. Kessler was the commissioner of the Food and Drug Administration (FDA) from November 8, 1990, to February 28, 1997. He co-chaired the Biden-Harris transition’s COVID-19 Advisory Board from November 2020 to January 2021 and was the head of Operation Warp Speed, the U.S. government program to accelerate the development of COVID-19 vaccines and other treatments, from January to February 2021.

Viceroy is an American brand of cigarettes, currently owned and manufactured by R. J. Reynolds Tobacco Company in the United States and British American Tobacco outside of the United States.

Operation Berkshire is the name of a program initiated in 1976 by seven of the world's major tobacco companies aimed at promoting "controversy" over smoking and disease.

<span class="mw-page-title-main">Menthol cigarette</span> Cigarette flavored with the compound menthol

A menthol cigarette is a cigarette infused with the compound menthol which imparts a “minty” flavor to the smoke. Menthol also decreases irritant sensations from nicotine by desensitizing receptors, making smoking feel less harsh compared to regular cigarettes. Some studies have suggested that they are more addictive. Menthol cigarettes are just as hard to quit and are just as harmful as regular cigarettes.

<span class="mw-page-title-main">Electronic cigarette</span> Device that vaporizes a liquid nicotine solution for inhalation

An electronic cigarette, also called vape is a device that simulates tobacco smoking. It consists of an atomizer, a power source such as a battery, and a container such as a cartridge or tank filled with liquid. Instead of smoke, the user inhales vapor. As such, using an e-cigarette is often called "vaping". The atomizer is a heating element that vaporizes a liquid solution called e-liquid, which quickly cools into an aerosol of tiny droplets, vapor and air. E-cigarettes are activated by taking a puff or pressing a button. Some look like traditional cigarettes, and most kinds are reusable. The vapor mainly comprises propylene glycol and/or glycerin, usually with nicotine and flavoring. Its exact composition varies, and depends on several things including user behavior.

<span class="mw-page-title-main">Types of tobacco</span>

This article contains a list of tobacco cultivars and varieties, as well as unique preparations of the tobacco leaf involving particular methods of processing the plant.

<span class="mw-page-title-main">Family Smoking Prevention and Tobacco Control Act</span>

The Family Smoking Prevention and Tobacco Control Act, is a federal statute in the United States that was signed into law by President Barack Obama on June 22, 2009. The Act gives the Food and Drug Administration the power to regulate the tobacco industry. A signature element of the law imposes new warnings and labels on tobacco packaging and their advertisements, with the goal of discouraging minors and young adults from smoking. The Act also bans flavored cigarettes, places limits on the advertising of tobacco products to minors and requires tobacco companies to seek FDA approval for new tobacco products.

Dissolvable tobacco is a tobacco product that dissolves in the mouth. Major tobacco manufacturers that sell dissolvable tobacco products include R. J. Reynolds Tobacco Company. Research into health effects of dissolvable and other new tobacco products was among the reasons of the establishment of the Tobacco Products Scientific Advisory Committee of the Food and Drug Administration in 2009.

<span class="mw-page-title-main">Regulation of tobacco by the U.S. Food and Drug Administration</span>

Regulation of tobacco by the U.S. Food and Drug Administration began in 2009 with the passage of the Family Smoking Prevention and Tobacco Control Act by the United States Congress. With this statute, the Food and Drug Administration (FDA) was given the ability to regulate tobacco products.

DNA Plant Technology was an early pioneer in applying transgenic biotechnology to problems in agriculture. The company was founded in Cinnamonson, New Jersey, and moved to California in 1994. Some of the plants and products they developed included vine sweet mini peppers, the Fish tomato and Y1 tobacco. In 1996 the company merged with the Mexican conglomerate Empresas La Moderna, through its Bionovo subsidiary. In 2002, Bionova shut down DNA Plant Technology.

Alix Marian Freedman is an American journalist, and ethics editor at Thomson Reuters.

<span class="mw-page-title-main">Regulation of electronic cigarettes</span> International regulations

Regulation of electronic cigarettes varies across countries and states, ranging from no regulation to banning them entirely. As of 2015, around two thirds of major nations have regulated e-cigarettes in some way.

A heated tobacco product (HTP) is a tobacco product that heats the tobacco at a lower temperature than conventional cigarettes. These products contain nicotine, which is a highly addictive chemical. The heat generates an aerosol or smoke to be inhaled from the tobacco, which contains nicotine and other chemicals. HTPs may also contain additives not found in tobacco, including flavoring chemicals. HTPs generally heat tobacco to temperatures under 600 °C (1100 °F), a lower temperature than conventional cigarettes.

References

  1. 1 2 "Inside the Tobacco Deal - interview with David Kessler". PBS. 2008. Retrieved 2008-06-11.
  2. 1 2 "The Tobacco Industry Documents: What Do They Tell Us About The Industry in Brazil?" (PDF). Pan American Health Organization. May 2007. Retrieved 2008-06-11.
  3. 1 2 3 4 5 6 Pringle, Peter (1998-02-22). "Tobacco giant bred high-nicotine crop in attempt to keep smokers interested". The Observer .
  4. 1 2 3 "The Future of Y1". University of California, San Francisco. 1990. Archived from the original on 2008-08-21. Retrieved 2008-06-11.
  5. 1 2 3 "Chronology of Significant Y1 Events". Brown & Williamson. 1995-06-26. Retrieved 2008-06-12.
  6. 1 2 Seper, Jerry (1998-01-08). "Justice uproots 'crazy tobacco'; Prosecutors target high-nicotine leaf". The Washington Times . p. A4.
  7. ↑ Leavell, N.-R. (1999). "The Low Tar Lie". Tobacco Control. British Medical Journal. 8 (4): 433–437. doi: 10.1136/tc.8.4.433 . PMC   1759759 . PMID   10629251.
  8. ↑ "Evaluation of Y1 Tobacco". British American Tobacco. 1991-11-21. Archived from the original on 2002-07-25. Retrieved 2008-06-11.
  9. ↑ "Note for Tobacco Strategy Review Team". British American Tobacco. November 1991. Archived from the original on 2008-10-20. Retrieved 2008-06-11.
  10. 1 2 Mishra, Raja (1998-03-07). "Despite pledge, cigarette still include high-nicotine tobacco/Brown & Williamson's CEO said four years ago the practice would stop. Newly released papers also indicate he misled Congress". The Philadelphia Inquirer . p. A3.
  11. 1 2 3 4 Rhodes, Tom (1994-06-24). "Tobacco chiefs who 'lied' to Congress could be charged". The Times .
  12. 1 2 "United States of America v. DNA Plant Technology Corporation". US District Court for the District of Columbia. 1998-01-07. Archived from the original on 2009-01-29. Retrieved 2008-06-12.
  13. 1 2 Kleiner, Kurt (1998-01-17). "The dragnet closes in - Tobacco sleuths have put a biotech company in the dock". New Scientist . Retrieved 2008-06-12.
  14. ↑ United States Supreme Court (2000-03-21). "Food and Drug Administration et al. v. Brown & Williamson Tobacco Corp. et al". FindLaw . Retrieved 2008-06-12.
  15. ↑ Cunningham, Rob (1996). Smoke & Mirrors: The Canadian Tobacco War. International Development Research Centre. ISBN   978-1-55250-025-5 . Retrieved 2008-06-11.
  16. ↑ "State of Minnesota Plaintiff Trial Exhibits". Tobacco Resource Center. 2005. Archived from the original on 2008-05-09. Retrieved 2008-06-11.
  17. ↑ Geyelin, Milo (1998-11-23). "Forty-Six States Agree to Accept $206 Billion Tobacco Settlement". Wall Street Journal .

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.